Publicaciones de los grupos de investigación: Marzo - Abril 2015

Cáncer del desarrollo

• Brosa M, García Del Muro X, Mora J, Villacampa A, Pozo-Rubio T, Luaces C, Montoto C. Orphan drugs revisited: cost-effectiveness analysis of the addition of mifamurtide to the conventional treatment of osteosarcoma. Expert Rev Pharmacoecon Outcomes Res 2015. 15: 331-340. FI: 1,870(Q2)Mora J, Modak S, Cheung NK, Meyers P, de Alava E, Kushner B, Magnan H, Tirado OM, Laquaglia M, Ladanyi M, Rosai J. Desmoplastic small round cell tumor 20 years after its discovery. Future Oncol 2015. 11: 1071-1081.FI: 2,611(Q3)

Enfermedades neurológicas minoritarias de base genética en el ámbito pediátrico

• Brito S, Thompson K, Campistol, J, Hardy S, Langping H, Fernández-Marmiesse A, Palacios L, Tischner C, Wenz T, McFarland R, Taylor R. Long-term survival in a child with severe encephalopathy, multiple respiratory chain deficiency and GFM1 mutations.. Front Genet 2015. 6: 102.
• Garcia-Cazorla A, Cortes-Saladelafont E, Duarte S. Comunicación neuronal y metabolismo sináptico en epilepsia infantil.. Rev Neurol 2015. 60: 219-228. FI: 0,926(Q4)
• Reddy P, Ocampo A, Suzuki K, Luo J, Bacman SR, Williams SL, Sugawara A, Okamura D, Tsunekawa Y, Wu J, Lam D, Xiong X, Montserrat N, Esteban CR, Liu GH, Sancho-Martinez I, Manau D, Civico S, Cardellach F, Del MarO'Callaghan M, Campistol J, Zhao H, Campistol JM, Moraes CT, Izpisua Belmonte JC. Selective elimination of mitochondrial mutations in the germline by genome editing.. Cell 2015. 161: 459-469. FI: 33,116(Q1)

Enfermedades en la edat adulta de origen fetal o en los primeros años de vida

• Iglesias-Platas I, Martín Trujillo A, Court F, Monk D. Distinct promoter methylation and isoform-specific expression of RASFF1A in placental biopsies from complicated pregnancies.. Placenta 2015. 36: 397-402. FI:3,285(Q1)
• Martín-Ancel A, Balaguer A, García-Alix A. Duración de la reanimación en neonatos con Apgar a los 10min menor de 3 en la era de la hipotermia.. An Pediatr (Barc) 2015. 82: 129-130. FI: 0,722(Q3)
• Moore GE, Ishida M, Demetriou C, Al-Olabi L, Leon LJ, Thomas AC, Abu-Amero S, Frost JM, Stafford JL, Chaoqun Y, Duncan AJ, Baigel R, Brimioulle M, Iglesias-Platas I, Apostolidou S, Aggarwal R, Whittaker JC,Syngelaki A, Nicolaides KH, Regan L, Monk D, Stanier P. The role and interaction of imprinted genes in human fetal growth.. Philos Trans R Soc Lond B Biol Sci 2015. 370: 20140074-0. FI: 6,314(Q1)
• Verd S, Porta R, Botet F, Gutiérrez A, Ginovart G, Barbero AH, Ciurana A, Plata II. Hospital Outcomes of Extremely Low Birth Weight Infants After Introduction of Donor Milk to Supplement Mother's Milk.. Breastfeed Med 2015. 10: 150-155. FI: 1,733(Q2)

Enfermedades infecciosas y respuesta inflamatoria sistémica

• Fortuny C, Deyà Á, Chiappini E, Galli L, De Martino M, Noguera-Julian A. Metabolic and Renal Adverse Effects of Antiretroviral Therapy in HIV-Infected Children and Adolescents.. Pediatr Infect Dis J 2015. : -0. FI: 3,135(Q1)
• Del Amo E, Selva L, de Sevilla MF, Ciruela P, Brotons P, Triviño M, Hernandez S, Garcia-Garcia JJ, Dominguez A,Muñoz-Almagro C. Estimation of the invasive disease potential of Streptococcus pneumoniae in children by theuse of direct capsular typing in clinical specimens.. Eur J Clin Microbiol Infect Dis 2015. 34: 705-711. FI:2,544(Q2)
• Falcon-Neyra L, Benmarzouk-Hidalgo OJ, Madrid L, Noguera-Julian A, Fortuny C, Neth O, López-Cortés L. No Differences of Immune Activation and Microbial Translocation Among HIV-infected Children Receiving Combined Antiretroviral Therapy or Protease Inhibitor Monotherapy.. Medicine (Baltimore) 2015. 94: -0. FI:4,867(Q1)
• Giancane G, Ter Haar NM, Wulffraat N, Vastert SJ, Barron K, Hentgen V, Kallinich T, Ozdogan H, Anton J,Brogan P, Cantarini L, Frenkel J, Galeotti C, Gattorno M, Grateau G, Hofer M, Kone-Paut I, Kuemmerle-DeschnerJ, Lachmann HJ, Simon A, Demirkaya E, Feldman B, Uziel Y, Ozen S. Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever.. Ann Rheum Dis 2015. 74: 635-641. FI: 9,270(Q1)
• Gomez B, Hernandez-Bou S, Garcia-Garcia JJ, Mintegi S. Bacteremia in previously healthy children in emergency departments: clinical and microbiological characteristics and outcome.. Eur J Clin Microbiol Infect Dis 2015. 34: 453-460. FI: 2,544(Q2)
• Guix-Comellas EM, Rozas-Quesada L, Force-Sanmartín E, Estrada JM, Galimany J. Influence of nursing interventions on adherence to treatment with antituberculosis drugs in the paediatric population: research protocol.. J Adv Nurs 2015. : -0. FI: 1,685 (Q1)
• Fumadó V, Trilla A. Enfermedad por virus Ébola: un año después.. An Pediatr (Barc) 2015. 82: 125-128. FI:0,722(Q3)

Etiopatogenia y tratamiento de los trastornos mentals graves

• Huerta-Ramos E, Ochoa S, Roca M, Miquel E, Usall J. The effect of raloxifene on symptoms and cognitive functioning in a postmenopausal schizophrenia patient: a case report.. Arch Womens Ment Health 2015. 18:259-261. FI: 2,009(Q3)

Grupo de Investigación en Enfermería, Educación y Sociedad (GIIES)

• Juvé E, Fabrellas N, Delgado P, Hurtado B, Martí M, Gironés M, García-Berman RM, Alonso S. Newbornphysiological immaturity: a concept analysis.. Adv Neonatal Care 2015. 15: 86-93.

Influencia del entorno en el bienestar del niño y el adolescente

• Brosa M, García Del Muro X, Mora J, Villacampa A, Pozo-Rubio T, Luaces C, Montoto C. Orphan drugs revisited: cost-effectiveness analysis of the addition of mifamurtide to the conventional treatment of osteosarcoma.. Expert Rev Pharmacoecon Outcomes Res 2015. 15: 331-340. FI: 1,870(Q2)

Impacto, riesgo y prevención de los trastonos mentales

• Hardt J, Bernert S, Matschinger H, Angermeier MC, Vilagut G, Bruffaerts R, de Girolamo G, de Graaf R, Haro JM, Kovess V, Alonso J. Suicidality and its relationship with depression, alcohol disorders and childhood experiences of violence: Results from the ESEMeD study. J Affect Disord 2015. 175: 168-174. FI: 3,705(Q1)
• Santini ZI, Koyanagi A, Tyrovolas S, Mason C, Haro JM. The association between social relationships and depression: A systematic review.. J Affect Disord 2015. 175C: 53-65. FI: 3,705(Q1)
• Tyrovolas S, Koyanagi A, Garin N, Olaya B, Ayuso-Mateos JL, Miret M, Chatterji S, Tobiasz-Adamczyk B,Koskinen S, Leonardi M, Haro JM. Diabetes mellitus and its association with central obesity and disability among older adults: A global perspective.. Exp Gerontol 2015. 64: 70-77. FI: 3,529(Q1)
• Stickley A, Koyanagi A, Roberts B, Leinsalu M, Goryakin Y, McKee M. Smoking status, nicotine dependence and happiness in nine countries of the former Soviet Union.. Tob Control 2015. 24: 190-197. FI: 5,150(Q1)

Tencologías sanitarias y resultados en Atención Primaria y Salud Mental (PRISMA)

• Ferrer M, Andion O, Bendeck M, Calvo N, Prat M, Aragones E, Barral C, Casas M, Salvador-Carulla L. Regional analysis of health service utilisation by persons with borderline personality disorders: implications for evidence informedpolicy.. J Ment Health Policy Econ 2015. 18: 17-25. FI: 1,406(Q3)
• Rubio-Valera M, Ortiz JM, Gracia, A.. Health service use and costs associated with aggressiveness or agitation and containment in adult psychiatric care: a systematic review of the evidence.. BMC Psychiatry 2015. : -0. FI:2,237(Q2)